Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Mar 2026: UnitedHealth Group completed the sale of Optum UK, whose core business is EMIS, to private equity firm TPG; terms were not officially disclosed, though Sky News had reported a value of about £1.2bn–£1.4bn.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving EMIS found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
No regulatory actions or clinical safety incidents attributed to EMIS products found in HSH's search of the last 24 months.
Contract delivery, go-lives, terminations and disputes.
No significant new contracts, terminations or customer disputes involving EMIS found in HSH's search of the last 24 months.